Walaiporn Wangchinda
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
44
Citations
290
Est. group size
~4
Recurring co-author estimate
Active years
9
Publishing since 2018
Typically publishes in teams of ~6 · 5% small-team papers (≤3 authors) · across 19 venues
- P-1211. Effectiveness of iMIpenem-Relebactam for multidrug-resistant Pseudomonas AeruGinosa in pnEumonia and bloodstream infections in the United States (MIRAGE)
Open Forum Infectious Diseases · 2026
- Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
UNC Libraries · 2026
- New Perspectives on Antimicrobial Agents: Sulbactam-durlobactam
Antimicrobial Agents and Chemotherapy · 2025
- Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE)
Antimicrobial Agents and Chemotherapy · 2025
- P-1105. Effectiveness of Imipenem-Relebactam for Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Pneumonia and Bloodstream Infections in the United States (MIRAGE)
Open Forum Infectious Diseases · 2025
- P-639. Development of antimicrobial resistance in patients with pneumonia due to <i>P.aeruginosa</i> treated with cefepime or piperacillin-tazobactam
Open Forum Infectious Diseases · 2025
- P-1697. Antibiotic prescribing patterns among outpatients with acute sinusitis in Michigan
Open Forum Infectious Diseases · 2025
- 312. Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i> infections in the United States (CACTUS)
Open Forum Infectious Diseases · 2025
- 311. Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i> infections in the United States (CACTUS)
Open Forum Infectious Diseases · 2025
- Cluster-Randomized Controlled Trial of Enhanced Carbapenem-Resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital
Clinical Infectious Diseases · 2025
- Recurrent granulomatous mastitis associated with breast sparganosis: a case report
International Journal of Infectious Diseases · 2025
- Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
Open MIND · 2025
- Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
The Lancet Infectious Diseases · 2024
- Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections
Journal of Antimicrobial Chemotherapy · 2024
- A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant <i>Pseudomonas aeruginosa</i>
Journal of Antimicrobial Chemotherapy · 2024
- Open Forum Infectious Diseases×16
- Antibiotics×7
- Antimicrobial Agents and Chemotherapy×3
- BMC Infectious Diseases×2
- Journal of Antimicrobial Chemotherapy×2
- Keith S. Kaye
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Samuel L Aitken
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Jason M. Pogue
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Karen Bush
Biochemistry, Genetics and Molecular Biology · Indiana University
- Paul Lephart
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile